Anti-atherogenic Modification of Serum Lipoprotein Function in Patients with Rheumatoid Arthritis after Tocilizumab Treatment, a Pilot Study

Lipid metabolism derangement contributes to increased cardiovascular risk in Rheumatoid Arthritis (RA). It is still debated whether and how tocilizumab, an interleukin-6 receptor inhibitor used in active RA, impacts cardiovascular risk. We studied the effect of tocilizumab on the regulation of macro...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Daniela Greco, Roberta Gualtierotti, Pasquale Agosti, Maria Pia Adorni, Francesca Ingegnoli, Matteo Rota, Franco Bernini, Pier Luigi Meroni, Nicoletta Ronda
Formato: Artigo
Idioma:Inglês
Publicado em: MDPI AG 2020-07-01
Colecção:Journal of Clinical Medicine
Assuntos:
cardiovascular disease
tocilizumab
rheumatoid arthritis
atherosclerosis
lipoproteins
cellular cholesterol
Acesso em linha:https://www.mdpi.com/2077-0383/9/7/2157
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados